Robert Yarchoan, M.D.
National Cancer Institute (NCI) · National Cancer Institute, National Institutes of Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert Yarchoan, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05907759 · Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman DiseaseNational Cancer Institute (NCI) · recruiting · Lymphoma, Primary Effusion · principal investigator
- N/ANCT03300830 · Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman DiseaseNational Cancer Institute (NCI) · recruiting · Human Immunodeficiency Virus, Castleman's Disease, Kaposi's Sarcoma · principal investigator
- Ph1/Ph2NCT01495598 · Pomalidomide for Kaposi Sarcoma in People With or Without HIVNational Cancer Institute (NCI) · completed · Kaposi Sarcoma, Sarcoma, Kaposi · principal investigator
- Ph2NCT01441063 · Tocilizumab for KSHV-Associated Multicentric Castleman DiseaseNational Cancer Institute (NCI) · completed · Castleman Disease, Multicentric Castleman Disease, Giant Lymph Node Hyperplasia · principal investigator
- Ph2NCT01419561 · Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)National Cancer Institute (NCI) · recruiting · KSHV Inflammatory Cytokine Syndrome (KICS), KSHV, HHV-8 · principal investigator
- Ph2NCT00923936 · Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s SarcomaNational Cancer Institute (NCI) · completed · Sarcoma, Kaposi · principal investigator
- Ph1NCT00287495 · BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's SarcomaNational Cancer Institute (NCI) · terminated · Kaposi's Sarcoma, HHV-8, KSHV · principal investigator
- Ph2NCT00267865 · Chemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaNational Cancer Institute (NCI) · completed · AIDS-Related-Primary Central Nervous System Lymphoma · principal investigator
- Ph2NCT00092222 · Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityNational Cancer Institute (NCI) · active not recruiting · Lymphoproliferative Disorder, HHV-8, Malignancy · principal investigator
- Ph2NCT00055237 · Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative PatientsNational Cancer Institute (NCI) · completed · Kaposi's Sarcoma, HIV Infections, HIV Seronegativity · principal investigator
- N/ANCT00026793 · Assessment of Blood Vessel Density in Kaposi's Sarcoma LesionsNational Cancer Institute (NCI) · completed · Kaposi's Sarcoma · principal investigator
- N/ANCT00006518 · Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerNational Cancer Institute (NCI) · recruiting · HIV, Kaposi's Sarcoma, Lymphomas · principal investigator
- N/ANCT00006171 · Effects of Potent Antiretroviral Therapy on Kaposi s SarcomaNational Cancer Institute (NCI) · completed · HIV Seropositivity, Kaposi's Sarcoma, HIV Infections · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 8 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.